| Home use of an artificial beta cell in type 1 diabetes H Thabit, M Tauschmann, JM Allen, L Leelarathna, S Hartnell, ... New England Journal of Medicine 373 (22), 2129-2140, 2015 | 525 | 2015 |
| Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis E Bekiari, K Kitsios, H Thabit, M Tauschmann, E Athanasiadou, ... bmj 361, 2018 | 470 | 2018 |
| Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial M Tauschmann, H Thabit, L Bally, JM Allen, S Hartnell, ME Wilinska, ... The Lancet 392 (10155), 1321-1329, 2018 | 442 | 2018 |
| Coming of age: the artificial pancreas for type 1 diabetes H Thabit, R Hovorka Diabetologia 59 (9), 1795-1805, 2016 | 268 | 2016 |
| Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial R Hovorka, D Elleri, H Thabit, JM Allen, L Leelarathna, R El-Khairi, ... Diabetes care 37 (5), 1204-1211, 2014 | 251 | 2014 |
| Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European … O Moser, MC Riddell, ML Eckstein, P Adolfsson, R Rabasa-Lhoret, ... Diabetologia 63 (12), 2501-2520, 2020 | 248 | 2020 |
| Subjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1α/mitofusin-2 regulatory pathway in response to physical activity MI Hernández-Alvarez, H Thabit, N Burns, S Shah, I Brema, M Hatunic, ... Diabetes care 33 (3), 645-651, 2010 | 225 | 2010 |
| Closed-loop insulin delivery for glycemic control in noncritical care L Bally, H Thabit, S Hartnell, E Andereggen, Y Ruan, ME Wilinska, ... New England Journal of Medicine 379 (6), 547-556, 2018 | 219 | 2018 |
| Patients’ and caregivers’ experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study J Lawton, M Blackburn, J Allen, F Campbell, D Elleri, L Leelarathna, ... BMC endocrine disorders 18, 1-10, 2018 | 188 | 2018 |
| Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study H Thabit, A Lubina-Solomon, M Stadler, L Leelarathna, E Walkinshaw, ... The lancet Diabetes & endocrinology 2 (9), 701-709, 2014 | 186 | 2014 |
| Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents KD Barnard, T Wysocki, JM Allen, D Elleri, H Thabit, L Leelarathna, ... BMJ Open Diabetes Research and Care 2 (1), e000025, 2014 | 175 | 2014 |
| Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study L Leelarathna, S Dellweg, JK Mader, JM Allen, C Benesch, W Doll, ... Diabetes Care 37 (7), 1931-1937, 2014 | 160 | 2014 |
| Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open … L Bally, H Thabit, H Kojzar, JK Mader, J Qerimi-Hyseni, S Hartnell, ... The Lancet Diabetes & Endocrinology 5 (4), 261-270, 2017 | 158 | 2017 |
| Day-and-night hybrid closed-loop insulin delivery in adolescents with type 1 diabetes: a free-living, randomized clinical trial M Tauschmann, JM Allen, ME Wilinska, H Thabit, Z Stewart, P Cheng, ... Diabetes Care 39 (7), 1168-1174, 2016 | 134 | 2016 |
| Closing the loop in adults, children and adolescents with suboptimally controlled type 1 diabetes under free living conditions: a psychosocial substudy KD Barnard, T Wysocki, V Ully, JK Mader, TR Pieber, H Thabit, ... Journal of diabetes science and technology 11 (6), 1080-1088, 2017 | 132 | 2017 |
| Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial L Leelarathna, SW English, H Thabit, K Caldwell, JM Allen, ... Critical Care 17, 1-12, 2013 | 132 | 2013 |
| Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial H Thabit, S Hartnell, JM Allen, A Lake, ME Wilinska, Y Ruan, ML Evans, ... The lancet Diabetes & endocrinology 5 (2), 117-124, 2017 | 130 | 2017 |
| Intermittently scanned continuous glucose monitoring for type 1 diabetes L Leelarathna, ML Evans, S Neupane, G Rayman, S Lumley, I Cranston, ... New England Journal of Medicine 387 (16), 1477-1487, 2022 | 128 | 2022 |
| Psychosocial aspects of closed‐and open‐loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting KD Barnard, T Wysocki, H Thabit, ML Evans, S Amiel, S Heller, A Young, ... Diabetic Medicine 32 (5), 601-608, 2015 | 126 | 2015 |
| Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK MJ Carr, AK Wright, L Leelarathna, H Thabit, N Milne, N Kanumilli, ... The Lancet. Diabetes & Endocrinology 9 (7), 413, 2021 | 112 | 2021 |
